- Home
- RAPT vs PTMN Comparison
RAPT vs PTMN Comparison
Compare RAPT & PTMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- PTMN
- Stock Information
- Founded
- RAPT 2015
- PTMN 2006
- Country
- RAPT United States
- PTMN United States
- Employees
- RAPT N/A
- PTMN N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- PTMN Finance: Consumer Services
- Sector
- RAPT Health Care
- PTMN Finance
- Exchange
- RAPT Nasdaq
- PTMN Nasdaq
- Market Cap
- RAPT 117.5M
- PTMN 113.0M
- IPO Year
- RAPT 2019
- PTMN N/A
- Fundamental
- Price
- RAPT $0.92
- PTMN $11.92
- Analyst Decision
- RAPT Buy
- PTMN Hold
- Analyst Count
- RAPT 5
- PTMN 1
- Target Price
- RAPT $5.25
- PTMN $14.00
- AVG Volume (30 Days)
- RAPT 1.1M
- PTMN 45.7K
- Earning Date
- RAPT 05-08-2025
- PTMN 05-08-2025
- Dividend Yield
- RAPT N/A
- PTMN 19.75%
- EPS Growth
- RAPT N/A
- PTMN N/A
- EPS
- RAPT N/A
- PTMN N/A
- Revenue
- RAPT N/A
- PTMN $58,024,000.00
- Revenue This Year
- RAPT N/A
- PTMN N/A
- Revenue Next Year
- RAPT N/A
- PTMN $7.60
- P/E Ratio
- RAPT N/A
- PTMN N/A
- Revenue Growth
- RAPT N/A
- PTMN N/A
- 52 Week Low
- RAPT $0.71
- PTMN $11.60
- 52 Week High
- RAPT $4.60
- PTMN $20.10
- Technical
- Relative Strength Index (RSI)
- RAPT 49.00
- PTMN 41.65
- Support Level
- RAPT $0.86
- PTMN $12.00
- Resistance Level
- RAPT $1.27
- PTMN $12.84
- Average True Range (ATR)
- RAPT 0.13
- PTMN 0.29
- MACD
- RAPT 0.01
- PTMN 0.03
- Stochastic Oscillator
- RAPT 34.50
- PTMN 29.91
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About PTMN Portman Ridge Finance Corporation
Portman Ridge Finance Corp Inc is a non-diversified closed-end investment company. The company originates, structures, and invests in secured term loans, bonds or notes, and mezzanine debt primarily in privately-held middle market companies but may also invest in other investments such as loans to publicly traded companies, high-yield bonds, and distressed debt securities. The company's investment objective in the Debt securities portfolio is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt, and selected equity investments in privately-held middle market companies.